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Glutathione is a small tripeptide to maintain overall reducing environment in vivo. Reduced endogenous glutathione level has been associated
with aging, obesity and diabetes. In this study, the direct impact of low endogenous glutathione level on energy homeostasis is investigated at
molecular level. Depletion of endogenous glutathione in rat primary hepatocytes by BSO, an inhibitor of γ-glutamylcysteine synthase, leads to
reduced mRNA levels of several key enzymes in energy homeostasis, including phosphoenolpyruvate carboxylkinase (PEPCK), the rate-limiting
enzyme in gluconeogenesis. Supplementation of various reducing reagents, including N-acetylcysteine, DTTand glutathione, reverses the inhibitory
effect of BSO on PEPCK mRNA level. The suppressive effect of BSO on PEPCK mRNA level is also reversed through co-treatment with either
SB210290, a specific p38 kinase inhibitor, or wortmannin and LY294002, the well-established PI-3 kinase inhibitors, suggesting the involvement of
these kinases in this process. These observations correlate well with the observations that reduced endogenous glutathione level and reduced
gluconeogenesis coincide with aging process, implying a causal relationship between these changes in aged population. More importantly, this study
suggests that endogenous glutathione level tightly associates with energy homeostasis at molecular level, identifying reduced endogenous
glutathione level as a potential contributing factor to dysregulated metabolic processes in aging, obese and diabetic populations. In addition, the
different responses of PEPCK expression to the alteration of endogenous glutathione level in rat hepatoma cells from primary hepatocytes raises
caution against using established cell lines in examining the dysregulated metabolic process related to altered endogenous glutathione level.
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Ageing is tightly associated with myriad changes of meta-
bolic processes, as demonstrated by the high prevalence of
various metabolic diseases including Alzheimer disease, dia-
betes, and cardiovascular diseases. Understanding the dysregu-
lated metabolic processes of ageing becomes critical to future
prevention and intervention of various ageing-associated meta-
bolic diseases.
A leading theory of aging is the Free Radical Theory of
Aging [1]. This theory proposes that free radicals, initiated by
the mitochondria, interfere with various biological processes
owing to their high reactivity. The excessive free radicals,
commonly defined as oxidative stress, are suggested to be⁎ Rigel Pharmaceuticals, Inc. 1180 Veterans Boulevard, South San Francisco,
CA 94080, USA.
E-mail address: jiandi.zhang@gmail.com.
0925-4439/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2007.10.001actively involved in signaling pathways mediating multiple
biological processes including aging.
One direct consequence of the accumulation of free radicals
is the disturbance of the overall reducing environment of the
cell. This reducing environment is maintained by various redox
couples, including glutathione system as the leading contributor
[2]. The tripeptide glutathione is the most abundant low
molecular weight thiol in vivo. It is maintained at mM level, 500
to 1000 fold higher than other redox couples. Glutathione exists
in either reducing (GSH) or oxidized forms (GSSG and GS-R)
[3]. The endogenous level of the reducing form of glutathione is
10 to 100 fold higher than that of the oxidized forms. Together
with superoxide dismutase, glutathione eliminates free radicals
accumulation in vivo, while itself is being converted to the
oxidized form, GSSG. Clearly, maintaining constant level of
endogenous glutathione is critical for normal cellular activities.
Low cellular glutathione level has been observed in liver,
kidney, and blood of aged animals [4,5]. Similar observations have
Fig. 1. Depletion of endogenous glutathione leads to global changes of cellular
metabolism. Rat primary hepatocytes were isolated as described inMaterials and
methods. (A) Cells were treated with either 100 nM insulin or 250 μM BSO for
16h before the total RNAwas extracted for quantitative real time PCR analysis
using primers described elsewhere [22]. The results are average of three
independent experiments in triplates. ⁎pb0.05 based on Student t-test. All the
results were normalized using rat 36B4 as internal control. The dashed line
indicates the expression level of the indicated gene in control cells. (B) Cells
were setup as in 1A and treated with either DMSO, 100 nM insulin, or BSO at
either 250 μM or 500 μM respectively. Total RNA was extracted for northern
blot analysis using probes against PEPCK, G-6-Pase, IGFBP-1, GK and ApoE.
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low glutathione level under these pathophysiological conditions is
still unclear, and it is also unclear if low endogenous glutathione
level contributes directly to the dysregulated metabolic process
commonly associated with aging, obesity and diabetes.
L-buthionine-[S,R]-sulfoximine (BSO) is a potent inhibitor
of γ-glutamylcysteine synthetase, the key enzyme in glutathi-
one synthesis. Treatment of BSO depletes endogenous glu-
tathione in cell culture and animal studies [8]. In this study,
endogenous glutathione level was lowered by BSO treatment,
and the effect of low glutathione level on cellular metabolism
was investigated. The results suggested that low glutathione
level might contribute directly to dysregulated metabolic pro-
cesses in vivo.
2. Materials and methods
2.1. General agents
Restriction and modifying enzymes were obtained from New England
Biolabs; Taq DNA polymerase was from Promega; RediPrimer DNA labeling
kit, [α-32P] dCTP and N-bond membrane were from Amersham Biosciences;
and Topo TA Cloning kit, Trizol reagent were from Invitrogen. ExpressHyb
Hybridization Solution was purchased from BD Clonetech. Insulin, Triiodo-
thyronine was purchased from Sigma. Dexamethasone was purchased from
BioMol. All the kinase inhibitors were purchased from EMD biosciences. Liver
digestion medium, liver perfusion medium, M199, DMEM medium and fetal
bovine serum were purchased from invitrogen. All the culture dishes were
purchased from BD Discover Labware. CM-H2DCFDA was purchased from
Invitrogen. All media were supplemented with Penicillin/streptomyocin
according to manufacturer's instructions.
2.2. Isolation of rat primary hepatocytes
Male Sprague–Dawley rats (250 g–300 g) were obtained from HarlanWorld
Headquarters (Indianapolis, Indiana). Animals were housed in colony cages,
maintained on a 12-h light/ 12-h dark cycle, and fed Teklad 4% chow diet. Rat
primary hepatocytes were isolated from nonfasting rats by collagenase method
[9]. Briefly, animals were anesthetized with halothane. Rat liver was perfused in
situ via the portal vein with 100 ml liver perfusion medium at a rate of ∼7 ml/
min. The liver was then perfused with Liver Digest Medium containing
collagenase for 20 min at a flow rate of 5 ml/min. After perfusion, the liver was
transferred to a 100-mm culture dish with Liver Digest Medium and the hepatic
capsules were stripped and shaken to dissociate cells in the medium. Cells were
filtered through a gauze and washed twice with ice cold DMEM (Invitrogen)
supplemented with 5% fetal bovine Serum before they were seeded in rat
collagen I-coated dishes (BD Labware) in M199 medium supplemented with 5%
fetal bovine serum. The cells were washed twice with DPBS after 4 h, and were
cultured in serum free M199 medium supplemented with 100 nM T3, 100 nM
Dexamethasone and 1 nM insulin overnight. Before treatment, cells were
washed twice with DPBS and changed into plain M199 medium supplemented
with 100 nM dexamethasone.
2.3. Northern blot analysis
Procedure has been described elsewhere [10]. In brief, Total RNA was
extracted using Trizol regent, and separated in 1% formaldehyde agarose gel
before they were transferred to nylon membrane for hybridization using probes
labeled with [α-32P] dCTP.
2.4. Glutathione measurement
Endogenous glutathione level was measured using modified Griffith method
[11]. In brief, cells were harvested and homogenized in glutathione reactionbuffer (125 mM Na3PO4, 6.3 mM EDTA, pH 7.5). Cytosol was separated
from pellet after centrifugation at 3000 rpm for 5 min in microcentrifuge
tube, and 4 μl cytosol was collected for protein measurement. The rest of
the cytosol was transferred to another tube and treated with half volume of 10%
5-sulfosialicyclic acid to precipitate soluble proteins. The treated cytosol was
spinned using microcentrifuge at 3000 rpm for another 5 min. The supernatant
was transferred into another tube and was neutralized using 4 M Triethanola-
mine (50 μl/ml). Aliquot of 40 μl from each sample was added into reaction
mixture (0.6 mM DTNB, 50 unit/ml bovine glutathione reductase, 0.3 mM
NADPH in 1 ml GSH buffer). The reaction was monitored using spectro-
photomer at 412 nm. The endogenous glutathione level was derived from
comparison of reaction kinetics with a reference curve.
1177J. Zhang / Biochimica et Biophysica Acta 1772 (2007) 1175–11812.5. Quantitative real time PCR
Total RNAwas prepared from rat primary hepatocytes using TriZol reagent
(Invitrogen). Equal amounts of RNA were treated with DNase I (DNA-free™;
Ambion, Inc.). First strand cDNAwas synthesized from 2 μg of DNase I-treated
total RNA with random hexamer primers using the ABI cDNA synthesis kit
(Applied Biosystems). The reactions contained, in a final volume of 20 μl, 20 ng
of reverse transcribed total RNA, 167 nM forward and reverse primers, and
10 μl of 2× SYBR Green PCR Master Mix (catalog no. 4312704; PerkinElmer
Life Sciences). PCR was carried out in 384-well plates using the ABI PRISM
7900HT Sequence Detection System (Applied Biosystems). All reactions were
done in triplicate. The relative amount of all mRNAs was calculated using the
comparative CT method [12]. 36B4 mRNA expression was used as the invariant
control for all studies.
2.6. Measurement of reactive oxygen species
The intracellular production of reactive oxygen species was determined by
measurement of the oxidation of CM-H2DCFDA to the fluorescent compoundFig. 2. Low endogenous glutathione level suppresses PEPCK expression at mRNA
increased mRNA level of PEPCK. Cells were treated with reducing form of glutathio
probes against either PEPCK or ApoE. (B) Time course study of BSO effect on PEPC
RNA was extracted for northern blot analysis using specific probes against PEPCK
primary hepatocytes were treated with BSO at final concentration of 10 μM, 50 μM, 2
using specific probes for PEPCK and ApoE. (D) Measurement of endogenous glutath
primary hepatocytes were seeded at 6×106/100 mm dish in M199 medium supple
indicated in the figure for 16 h. Endogenous glutathione level was measured using met
experiments were averaged and expressed as the percentage of the endogenous gluta
cells was around 7.5 nmol/mg cytosolic protein. ⁎pb0.05 based on Student t-test.CM-H2DCF with a Cytofluor II multiplate fluorimeter (Millipore). Rat primary
hepatocytes were seeded in a 96 well collagen-coated plate in M199 medium
supplemented with 100 nM Dexamethasone. Cells were treated as indicated in
the figure overnight, and washed once with M199 medium supplemented with
100 nM before they were changed into M199 medium containing 5 μM CM-
H2DCFDA for 30 min. Fluorescence was monitored at excitation and emission
wavelengths of 485 and 530 nm, respectively.
3. Results
To test the direct effect of low glutathione level on energy
homeostasis at molecular level, endogenous glutathione was
depleted by the use of BSO in rat primary hepatocytes. Cells were
treated with BSO at 250 μM for 16 h, alongside with 100 nM
insulin as positive control. The mRNA levels of several key en-
zymes in energy homeostasis, including those involved in glu-
cose homeostasis (glucose kinase, GK; phosphoenoylpyruvatelevel. (A) Incubation of cells with reduced form of glutathione significantly
ne (GSH) for 4 h, and total RNAwas extracted for northern blot analysis using
K expression. Cells were treated for 4, 8, 12, 16 h with 250 μMBSO before total
and ApoE. (C) Dose response study of BSO effect on PEPCK expression. Rat
50 μM, and 500 μM for 16 h. Total RNAwas extracted for northern blot analysis
ione level in cells treated with BSO at concentrations indicated in the figure. Rat
mented with 100 nM dexamethasone, and treated with BSO at concentrations
hod of Griffith [11] as described inMaterials and methods. The results from three
thione level of untreated cells. The endogenous level of glutathione in untreated
Fig. 3. Antioxidants inhibit suppressive effect of BSO on PEPCK expression.
(A) Supplementation of reduced form of glutathione abolished suppressive
effect of BSO on PEPCK mRNA level. Cells were treated with 250 μM BSO
for 16 h with and without co-treatment of 6 mM glutathione (GSH, reducing
form). Total RNA was extracted for northern blot analysis. (B) N-ace-
tylcysteine, like glutathione, reversed inhibitory effect of BSO on PEPCK
expression. Cells were treated with BSO for 16 h with and without co-
treatments of glutathione (GSH, 6 mM), N-acetylcystein (NAC, 5 mM) and
ascorbic acid (5 mM) respectively for 16 h. Total RNA was extracted for
northern blot analysis. Results are the representatives of at least three
experiments. (C) Rat hepatoma H4IIE cells were setup at 2×106/60 mm dish in
DMEM medium supplemented with 10% fetal bovine serum overnight before
they were changed into plain DMEM medium, with and without co-treatments
of BSO, glutathione, or insulin, as indicated in the figure. Cells were treated
overnight, and total mRNA was collected for northern blot analysis using
probes against PEPCK or ApoE, as described in Fig. 2.
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insulin growth factor binding protein 1, IGFBP-1) and lipid
metabolism (Fatty acid synthase, FAS; and sterol regulatory
element binding protein 1c, SREBP-1c), were measured using
real time PCR method (RT-PCR) (Fig. 1A). Consistent with
previous reports, insulin treatment significantly reduced mRNA
levels of PEPCK, G-6-P, IRS-2 and IGFBP-1, and increased
mRNA levels ofGK, FAS, and SREBP-1c. BSO treatment, on the
other hand, also significantly reduced mRNA levels of PEPCK,
IRS-2 and IGFBP-1. However, it had minimal effects on those of
G-6-Pase, GK, FAS, and SREBP-1c. The expression level of
Insulin receptor (IR) did not change under either insulin or BSO
treatment, thus serving as an internal control of the experiment.
This observation suggested that reduced endogenous level of
glutathione might directly interfere with energy homeostasis at
molecular level. The real time-PCR result was also confirmed
using northern blot analysis on selected genes (Fig. 1B).
The suppressive effect of BSO on PEPCK gene expres-
sion was further investigated to understand the molecular
mechanism underlying the regulatory effect of low glutathione
level on cellular metabolic processes. Endogenous glutathione
level was altered either through depletion of endogenous
glutathione (BSO treatment) or supplementation of exogenous
glutathione, and their effects on PEPCK expression were
analyzed using northern blot analysis (Fig. 2). Supplementation
of exogenous glutathione (GSH) for 4 h significantly increased
PEPCKmRNA level. Supplementation of exogenous GSSG also
slightly increased PEPCK mRNA level (data not shown). The
expression level of ApoE was used here and elsewhere as the
loading control andwas not changed in these treatments (Fig. 2A).
Cells incubated with several other reducing agents, like DTT
(5 mM) or N-acetylcysteine (5 mM), also significantly in-
creased PEPCKmRNA level in rat primary hepatocytes (data not
shown).
The suppressive effect of BSO on PEPCK mRNA level was
also demonstrated by both time course and dose response
studies (Fig. 2B and C). Incubation of cells with 250 μM BSO
in the initial 8 h had minimum effect on PEPCK mRNA level.
The suppressive effect of BSO was first observed after 12 h of
incubation, and was evident after 16 h (Fig. 2B). The slow
response of the mRNA level of PEPCK to BSO treatment
agreed well with the hypothesis that depletion of endogenous
glutathione, rather than BSO itself, suppresses PEPCK ex-
pression at transcriptional level. Dose response experiment in
Fig. 2C showed that after 16 h of treatment, BSO at 50 μM
already significantly reduced PEPCK mRNA level, and from
250 μM on, BSO reduced PEPCK mRNA to undetectable level.
The depleting effect of BSO on endogenous glutathione level
in rat primary hepatocytes was verified using glutathione assay
based on the method of Griffith [11]. Rat hepatocytes were treated
with increasing doses of BSO for 16 h, and endogenous glu-
tathione level was measured and normalized to cytosolic protein
level. Consistent with northern blot analysis (Fig. 2C), 10 μM
BSO had minimal effect on endogenous glutathione level. From
50 μM BSO on, BSO significantly depleted endogenous glu-
tathione, and at 250 μM, BSO reduced endogenous glutathione
level by 80%. Overall, these observations suggested that reducedendogenous glutathione level leads to reduced PEPCK expression
in rat primary hepatocytes.
This idea was further tested in the next experiment (Fig. 3A).
Exogenous glutathione was used to supplement low endoge-
nous glutathione level in BSO-treated cells, and the expression
level of PEPCK was examined. Consistent with previous re-
sults, incubating cells with exogenous glutathione increased
PEPCK mRNA level, while BSO treatment suppressed its ex-
pression. Co-incubation of cells with exogenous glutathione
reversed BSO effect on PEPCK mRNA level significantly
(compared lane 2 with lane 4), further supporting the hypothesis
that reduced endogenous glutathione level was the direct cause
of reduced mRNA level of PEPCK in rat primary hepatocytes.
Fig. 4. PI-3 kinase activation is required for the suppressive effect of BSO on
PEPCK expression. (A) Wortmannin abolished BSO effect on PEPCK
expression. Rat primary hepatocytes were treated with BSO at 250 μM,
alongside with PD98059 (50 μM), SB202190 (20 μM), Wortmannin (100 nM),
rapamycin (50 μM) and LY294002 (20 μM ) for 16 h. Total RNAwas extracted
for northern blot analysis (20 μg/lane). The PEPCK mRNA level under these
treatments were also quantified using ImageJ program. The result is the average
of three independent experiments. ⁎pb0.05. The dashed bar indicates the basal
level expression of PEPCK in control cells. (B) Dose responses study. Cells
were treated with BSO at 250 μM or 500 μM, alongside with wortmannin
(100 nM) for 16 h, and PEPCK mRNA level was analyzed using northern blot
analysis (20 μg/lane). All the results were repeated at least three times.
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cysteine (NAC) and ascorbic acid, were also co-incubated with
BSO in rat primary hepatocytes (Fig. 3B). Supplementation of
NAC significantly increased PEPCK mRNA level in BSO-
treated cells. Ascorbic acid, on the other hand, failed to reverse
BSO effect on PEPCK expression. In addition, DTT at 5 mM
was as effective as glutathione in reversing the inhibitory effect
of BSO on PEPCK expression level (data not shown). These
results were consistent with the redox potentials of these re-
ducing reagents, indicating that altered reducing environment of
the cell resulted from the depletion of endogenous glutathione
modulates PEPCK mRNA level.
The suppressive effect of BSO on PEPCK mRNA level was
also investigated in a rat hepatoma cell line, H4IIE cells
(Fig. 3C). As a positive control, treatment of insulin led to
significantly reduced PEPCK expression level. In contrast to rat
primary hepatocytes (Fig. 2A), however, incubation of 5 mM
glutathione with H4IIE cells had little effect on PEPCK mRNA
level (compare lane 1 with lane 3). What is more, BSO treat-
ment at 250 μM for 16 h had no suppressive effect on PEPCK
mRNA level (compare lane 1 with lane 4). In fact, consistent
with a previous report [13], BSO treatment slightly increased
basal level expression of PEPCK, and co-incubation of glu-
tathione had minimal effect on this stimulatory effect of BSO on
PEPCK expression. This experiment clearly demonstrated dras-
tic differences between immortalized cells and rat primary
hepatocytes in response to BSO treatment. The implications of
this observation will be discussed later.
To understand the molecular mechanism underlying the
suppressive effect of low glutathione level on PEPCK mRNA
level, a group of well-known kinase inhibitors were used to treat
cells to investigate the putative involvement of these kinase
cascades in this process. These inhibitors included PD 98059
(MEK inhibitor), Wortmannin and LY 294002 (PI-3 Kinase
inhibitors), rapamycin (p70S6 Kinase inhibitor) and SB-202190
(p38 inhibitor) (Fig. 4A). Treatment of PD 98059 had minimal
effect on the regulatory effect of BSO on PEPCK mRNA level.
Treatment of SB-202190 on the other hand, potently inhibited
BSO effect on PEPCK mRNA level. Furthermore, both LY
294002 and Wortmannin increased basal PEPCK mRNA level
significantly. Co-treatments of BSO and wortmannin or LY
294002 effectively abolished the suppressive effect of BSO on
PEPCK mRNA level. Treatment of rapamycin also significantly
increased the basal level expression of PEPCK. However, the
suppressive effect of BSO was not inhibited in the presence of
rapamycin (Compare Lane 9 and Lane 10). The involvement of
PI-3 kinase in this process was further confirmed in a dose
response study (Fig. 4B). Wortmannin at 100 nM significantly
abolished BSO effect at both 250 μM and 500 μM on PEPCK
mRNA level. These experiments strongly suggested that the
suppressive effect of BSO on PEPCK mRNA level was a
regulated process, and several kinases, including PI-3 kinase
and p38 kinase, were possibly involved in this process.
One important role of glutathione in vivo is to protect cells
from the accumulation of reactive oxygen species. Low en-
dogenous glutathione level may fail to prevent the accumulation
of free radicals and their toxic effect on cellular metabolism.The possibility that the suppressive effect of BSO on PEPCK
expression was the result of the accumulation of free radicals
was also investigated in the following studies. Total level of
reactive oxygen species was measured using Dichlorodihydro-
fluorescein derivatives (CM-H2DCFDA), a cell-permeable
indicator for reactive oxygen species (Fig. 5). Its fluorescence
intensity is used as the indicator of the endogenous level of
reactive oxygen species. Cells incubated with exogenous glu-
tathione alone showed reduced signal intensity. However, com-
pared with cells treated with DMSO, BSO treatment did not
lead to significantly increased signal intensity. These results
raised doubt on the direct involvement of the free radicals in
Fig. 5. BSO treatment is not associated with increased level of reactive oxygen
species (ROS). (A) Rat primary hepatocytes were seeded at 5×104/well in 96
well plate. Cells were treated with BSO (250 μM) and glutathione (5 mM) as
indicated in the figure for 16 h and the overall reactive oxygen species levels
were measured as described in Materials and methods. The fluorescence
intensity of cells treated with DMSO alone was arbitrary set as 1. The dashed
line indicates the basal level fluorescence intensity. This experiment has been
repeated at least three times. (B) Rat primary cells were setup as described in
Fig. 2, and treated with either hydrogen peroxide at indicated concentrations or
BSO at 250 μM for 16 h. Total RNAwas prepared for northern blot analysis as
described in Fig. 2.
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conclusion was also supported by the minimal effects of both
MnTBAP, a cell permeable superoxide dismutase mimetic [14]
and catalase (from bovine liver) on the suppressive effect of
BSO on PEPCK mRNA level (data not shown), suggesting that
superoxide is unlikely directly involved in the BSO effect on
PEPCK mRNA level. Ascorbic acid, a powerful agent to de-
toxify superoxide, also had minimal effect on the suppressive
effect of BSO on PEPCK mRNA level (Fig. 3B).
Furthermore, as a major component of reactive oxygen
species, hydrogen peroxide has been suggested to mediate a
variety of biological processes. Hydrogen peroxide was used to
treat rat primary hepatocytes for 16 h, alongside with BSO in
Fig. 5B. Clearly, hydrogen peroxide up to 3 mM had minimal
effect on the expression level of PEPCK, while BSO signif-
icantly suppressed PEPCK expression at mRNA level. This
experiment further suggested the unlikely involvement of ROS
in the suppressive effect of BSO on PEPCK mRNA level.
4. Discussion
The data presented here describe for the first time the
regulatory effect of low endogenous glutathione level on energyhomeostasis at molecular level. Through investigation of its
suppressive effect on PEPCK expression level, low endogenous
glutathione level is suggested to modulate cellular metabolism
in a PI-3 kinase-dependent pathway, without direct involvement
of reactive oxygen species. Thus, low endogenous glutathione
level, commonly associated with obesity, aging and diabetes,
may contribute directly to these dysregulated metabolic pro-
cesses. In addition, results from this study indicates that while
reactive oxygen species may be involved in multiple biological
processes, the putative direct impact of persistent disturbed
reducing environment on overall cellular metabolism cannot be
discounted. While further studies are required to verify these
findings, continuing investigation of the molecular mechanism
underlying the regulatory effect of endogenous glutathione level
on energy homeostasis is needed for the prevention and treat-
ment of these pathphysiological states.
The finding that low endogenous glutathione level suppresses
PEPCK expression at mRNA level is also consistent with reports
where reduced PEPCK expression is commonly observed in
aged rodent models. PEPCK is the rate-limiting enzyme in
gluconeogenesis. Its expression is primarily regulated at
transcriptional level, subjecting to multiple controls including
hormones and dietary carbohydrates [15]. In aged rodent
models, both mRNA level and enzymatic activity of PEPCK
are reduced significantly [16–20]. Considering that reduced
endogenous glutathione level is also commonly observed in
aging population, observations from this study suggest a causal
relationship between low endogenous glutathione level and
reduced PEPCK expression level, and possibility of alleviation
of aberrant energy homeostasis in aged population by increasing
endogenous glutathione level.
Antioxidants, as popular nutritional supplements, have been
suggested to prevent several diseases including cancer, diabetes
and aging. However, the beneficial effects of antioxidants are
evaluated mainly through population studies, and the results
remain controversial [21]. In this study, incubation of cells with
glutathione, DTT or N-acetylcysteine all significantly increase
basal level expression of PEPCK, while incubation cells with
ascorbic acids has no detectable effect on PEPCK expression.
These observations imply that some of nutritional values of
certain antioxidants may lie in their effects in restoring aberrant
expression levels of key enzymes resulting from low endoge-
nous glutathione level commonly associated with aging and
diabetes.
The drastic difference at PEPCK mRNA level in established
cell line vs. primary cells in response to altered glutathione level
was also unexpected (Fig. 3A and C). Observations from this
study indicate that up-regulation of PEPCK mRNA level in
response to BSO treatment in rat hepatoma cells may not be
directly related to the alteration of endogenous glutathione
level. Rather, it may be the result of increased oxidative stress,
as suggested in other study [13]. More importantly, the different
responses of PEPCK mRNA level to BSO treatment in es-
tablished cells vs. rat primary hepatocytes further emphasizes
the importance of using primary cells or animal tissues to
investigate metabolic process associated with the alteration of
endogenous glutathione level. While the underlying mechanism
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be observed in their response to hydrogen peroxide treatment.
H4IIE cells died within hours in the presence of 100 μM
Hydrogen Peroxide, while rat primary hepatocytes were re-
sistant to hydrogen peroxide treatment at mM range for couple
of days (data not shown). Presumably, compared with estab-
lished cell line, primary cells are more resistant to oxidative
stress. This may also explain why depletion of endogenous
glutathione in rat primary hepatocytes was not associated with
dramatic increase of ROS (Fig. 5). Nonetheless, these dif-
ferences raise concerns about studies based on established cell
lines to investigate biological process associated with altered
endogenous glutathione level [13]. Although compared with
established cell line, primary cells are more troublesome to
manipulate, and difficult for genetic manipulations, it remains
necessary experimental material for future investigation of bio-
logical processes associated with alteration of endogenous glu-
tathione level.
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